Here begins the text.

Revisions of PRECAUTIONS (FY2020)

Posted date Nonproprietary name
(Click on each drug name for more information
[only available in Japanese language])
Detailed information on revisions of PRECAUTIONS
(from MHLW)
Summary of investigation results
(from PMDA)
June 1,
2019
Selexipag PDF
PDF
The Appendix for draft revisions is not included. See the Detailed information on revisions of PRECAUTIONS.
Clopidogrel sulfate PDF
Clopidogrel sulfate/aspirin PDF
May 19,
2019
Insulin human (genetical recombination) PDF
PDF
Insulin aspart (genetical recombination)
Insulin glargine (genetical recombination)
Insulin aspart (genetical recombination) PDF
Insulin glulisine (genetical recombination) PDF
Insulin lispro (genetical recombination) PDF
Insulin lispro (genetical recombination)
Insulin lispro (genetical recombination) [Insulin lispro biosimilar 1]
Insulin human (genetical recombination) PDF PDF
Insulin human (genetical recombination)
Insulin aspart (genetical recombination)
Insulin glargine (genetical recombination)
Insulin detemir (genetical recombination)
Insulin glulisine (genetical recombination)
Insulin degludec (genetical recombination)
Insulin glargine (genetical  recombination) [Insulin glargine biosimilar 1]
Insulin glargine (genetical  recombination) [Insulin glargine biosimilar 2]
Insulin degludec (genetical recombination)/insulin aspart (genetical recombination)
Insulin lispro (genetical recombination) PDF
Insulin lispro (genetical recombination)
Insulin lispro mix preparation 25
Insulin lispro mix preparation 50
Insulin degludec (genetical recombination)/liraglutide (genetical recombination)
Insulin glargine (genetical recombination)/lixisenatide
Insulin lispro (genetical recombination) [Insulin lispro biosimilar 1]
Apalutamide PDF PDF
Fulvestrant PDF PDF

 

JCN 3010005007409

Shin-Kasumigaseki Building, 3-3-2 Kasumigaseki,
Chiyoda-ku, Tokyo 100-0013 Japan

  • Contact us
  • Access/Map

Copyright (C) Pharmaceuticals and Medical Devices Agency, All Rights Reserved.

000047444
0
Revisions of PRECAUTIONS (FY2020)
/english/safety/info-services/drugs/revision-of-precautions/0008.html
en